ReviewEssays in biochemistry2026
A guide to Direct Pathway Cloning (DiPaC) for natural product discovery.
Review in Essays in biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bacterial biosynthetic gene clusters.Essays in biochemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Natural products (NPs) are a major source of chemical diversity and bioactive molecules. Advances in genome sequencing and bioinformatic analysis have facilitated identification of biosynthetic gene clusters (BGCs) across diverse microorganisms and environments; however, experimental access to these pathways is often hindered by absence of genetic tools, limited availability of DNA, and complex genetic architectures. Direct Pathway Cloning (DiPaC) has emerged as an efficient and flexible synthetic biology approach to address these challenges. DiPaC combines long-amplicon PCR with in vitro DNA assembly, allowing simultaneous cloning and refactoring of biosynthetic pathways without the need for intermediate library construction, extensive in vivo recombination, or multiple antibiotic selection markers. The method provides broad flexibility in vector choice, host selection, and pathway architecture, facilitating promoter exchange, removal of inhibitory regulatory elements, and modular pathway reconstruction. This review highlights representative DiPaC applications spanning multiple NP classes and illustrates its utility in orphan BGC activation, probing biosynthetic logic, and combinatorial biosynthesis. In addition, we provide guidance on BGC selection, amplification of challenging sequences, and assembly strategies, addressing common technical obstacles. Future directions are discussed, positioning DiPaC as a cornerstone tool for modern NP research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.